Comparison Of Iqwig and G-BA Benefit Ratings in Oncology.

Value Health

Quintiles Consulting, Reading, UK.

Published: November 2014

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2014.08.1758DOI Listing

Publication Analysis

Top Keywords

comparison iqwig
4
iqwig g-ba
4
g-ba benefit
4
benefit ratings
4
ratings oncology
4
comparison
1
g-ba
1
benefit
1
ratings
1
oncology
1

Similar Publications

Background: For time-to-event endpoints, three additional benefit assessment methods have been developed aiming at an unbiased knowledge about the magnitude of clinical benefit of newly approved treatments. The American Society of Clinical Oncology (ASCO) defines a continuous score using the hazard ratio point estimate (HR-PE). The European Society for Medical Oncology (ESMO) and the German Institute for Quality and Efficiency in Health Care (IQWiG) developed methods with an ordinal outcome using lower and upper limits of the 95% HR confidence interval (HR-CI), respectively.

View Article and Find Full Text PDF

Background: Systemic therapy (ST) is a psychotherapeutic intervention in complex human systems (both psychological and interpersonal). Cognitive behavioural therapy (CBT) is an established treatment for children and adolescents with mental disorders. As methodologically rigorous systematic reviews on ST in this population are lacking, we conducted a systematic review and meta-analysis to compare the benefit and harm of ST (and ST as an add-on to CBT) with CBT in children and adolescents with mental disorders.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!